Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL

Sibold William John sold 11,583 Madrigal Pharmaceuticals, Inc. shares (Form 4)

Traded Sep 9 to Sep 11, 2026 · Filed Sep 11, 2026

From Sep 9 to Sep 11, 2026, Sibold William John (Director, President and CEO) sold 11,583 Madrigal Pharmaceuticals, Inc. shares at an average US$538.65 for US$6.24M under a trading plan, leaving 197,746 shares. Filed Sep 11, 2026 (Form 4).

Sold
11,583 shares
Price
US$538.65 average (US$527.88 to US$546.38)
Value
US$6.24M
Holding after
197,746 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 9, 2026Common StockSale131US$527.88209,198Direct
Sep 9, 2026Common StockSale347US$529.27208,851Direct
Sep 9, 2026Common StockSale522US$530.23208,329Direct
Sep 9, 2026Common StockSale368US$531.99207,961Direct
Sep 9, 2026Common StockSale512US$533.09207,449Direct
Sep 9, 2026Common StockSale396US$534.20207,053Direct
Sep 9, 2026Common StockSale644US$535.27206,409Direct
Sep 9, 2026Common StockSale1,040US$536.11205,369Direct
Sep 9, 2026Common StockSale640US$537.17204,729Direct
Sep 9, 2026Common StockSale520US$538.30204,209Direct
Sep 9, 2026Common StockSale215US$539.03203,994Direct
Sep 9, 2026Common StockSale505US$540.19203,489Direct
Sep 9, 2026Common StockSale362US$541.65203,127Direct
Sep 9, 2026Common StockSale160US$542.55202,967Direct
Sep 11, 2026Common StockSale60US$533.09202,907Direct
Sep 11, 2026Common StockSale106US$534.06202,801Direct
Sep 11, 2026Common StockSale218US$535.94202,583Direct
Sep 11, 2026Common StockSale160US$537.62202,423Direct
Sep 11, 2026Common StockSale687US$540.59201,736Direct
Sep 11, 2026Common StockSale368US$541.64201,368Direct
Sep 11, 2026Common StockSale1,202US$542.60200,166Direct
Sep 11, 2026Common StockSale1,539US$544.02198,627Direct
Sep 11, 2026Common StockSale761US$544.83197,866Direct
Sep 11, 2026Common StockSale120US$546.38197,746Direct

Source

View original at SEC

Related